Effects of Intravenous Immunoglobulins on Human Innate Immune Cells: Collegium Internationale Allergologicum Update 2024
International Archives of Allergy and Immunology · 2024
DOI: 10.1159/000539069 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Archives of Allergy and Immunology, 2024. Verfasst von Camilla Jandus und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Immunoglobulins, Intravenous, Immunity, Innate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 109 Literaturangaben.
Abstract (Originalsprache)
Background: Intravenous immunoglobulin (IVIg) has been used for almost 40 years in the treatment of autoimmune and systemic inflammatory diseases. Numerous cells are involved in the innate immune response, including monocytes/macrophages, neutrophils, dendritic cells, mast cells, basophils, eosinophils, natural killer cells, and innate lymphoid cells. Many studies have investigated the mechanisms by which IVIg down-modulates inflammatory and autoimmune processes of innate immune cells. However, questions remain regarding the precise mechanism of action in autoimmune or inflammatory conditions. The aim of this work was to review the immunomodulatory effect of IVIg on only human innate immune cells. A narrative review approach was chosen to summarize key evidence on the immunomodulatory effects of commercially available and unmodified IVIg on human innate immune cells. Summary: Numerous different immunomodulatory effects of IVIg have been reported, with some very different effects depending on the immune cell type and disease. Several limitations of the different studies were identified. Of the 77 studies identified and reviewed, 29 (37.7%) dealt with autoimmune or inflammatory diseases. Otherwise, the immunomodulatory effects of IVIg were studied only in healthy donors using an in vitro experimental approach. Some of the documented effects showed disease-specific effects, such as in Kawasaki disease. Various methodological limitations have also been identified that may reduce the validity of some studies. Key Message: As further insights have been gained into the various inflammatory cascades activated in immunological diseases, interesting insights have also been gained into the mechanism of action of IVIg. We are still far from discovering all the immunomodulatory mechanisms of IVIg.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
- Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.
- Geneva Center for Inflammation Research, Geneva, Switzerland.
- Translational Research Centre in Onco-Haematology (CRTOH), Geneva, Switzerland.
- Division of Immunology and Allergology, University Hospitals and Medical Faculty, Geneva, Switzerland.
Zitieren
APA
Jandus, C., & Jandus, P. (2024). Effects of Intravenous Immunoglobulins on Human Innate Immune Cells: Collegium Internationale Allergologicum Update 2024. International Archives of Allergy and Immunology. https://doi.org/10.1159/000539069
Vancouver
Jandus C, Jandus P. Effects of Intravenous Immunoglobulins on Human Innate Immune Cells: Collegium Internationale Allergologicum Update 2024. International Archives of Allergy and Immunology. 2024. doi:10.1159/000539069
BibTeX
@article{Jandus2024,
author = {Jandus, Camilla and Jandus, Peter},
title = {Effects of Intravenous Immunoglobulins on Human Innate Immune Cells: Collegium Internationale Allergologicum Update 2024},
journal = {International Archives of Allergy and Immunology},
year = {2024},
doi = {10.1159/000539069}
}
EUVIMED